Indeed, we found that MAP17 knockdown resulted in a ~ 40% reduction of ROS in SMMC-7721 and HCC-LM3 cells (Fig. 4a), while MAP17 overexpression increased ROS level in MHCC-97H cells (Fig. 4b). Here, PDZK1IP1 is linked to hepatocellular carcinoma.